Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients.

Heitz U, Papmeyer M, Studerus E, Egloff L, Ittig S, Andreou C, Vogel T, Borgwardt S, Graf M, Eckert A, Riecher-Rössler A.

World J Biol Psychiatry. 2018 Jun 25:1-10. doi: 10.1080/15622975.2018.1462532. [Epub ahead of print]

PMID:
29938562
2.

Brain derived Neurotropic Factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis.

Theleritis C, Fisher HL, Shäfer I, Winters L, Stahl D, Morgan C, Dazzan P, Breedvelt J, Sambath I, Vitoratou S, Russo M, Reichenberg A, Falcone MA, Mondelli V, O'Connor J, David A, McGuire P, Pariante C, Di Forti M, Murray RM, Bonaccorso S.

Schizophr Res. 2014 Oct;159(1):56-61. doi: 10.1016/j.schres.2014.07.013. Epub 2014 Sep 22.

PMID:
25171858
3.

Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis.

Ruiz de Azua S, Matute C, Stertz L, Mosquera F, Palomino A, de la Rosa I, Barbeito S, Vega P, Kapczinski F, González-Pinto A.

BMC Psychiatry. 2013 Jan 15;13:27. doi: 10.1186/1471-244X-13-27.

4.

Sex differences in cognitive functioning in at-risk mental state for psychosis, first episode psychosis and healthy control subjects.

Ittig S, Studerus E, Papmeyer M, Uttinger M, Koranyi S, Ramyead A, Riecher-Rössler A.

Eur Psychiatry. 2015 Feb;30(2):242-50. doi: 10.1016/j.eurpsy.2014.11.006. Epub 2014 Dec 30.

PMID:
25555341
5.

Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis.

Şimşek Ş, Gençoğlan S, Yüksel T, Kaplan İ, Aktaş H.

J Clin Psychopharmacol. 2015 Oct;35(5):596-9. doi: 10.1097/JCP.0000000000000378.

PMID:
26267416
6.

Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients.

Rizos EN, Papathanasiou M, Michalopoulou PG, Mazioti A, Douzenis A, Kastania A, Nikolaidou P, Laskos E, Vasilopoulou K, Lykouras L.

Schizophr Res. 2011 Jul;129(2-3):201-4. doi: 10.1016/j.schres.2011.03.011. Epub 2011 Apr 5.

PMID:
21470828
7.
8.

The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients.

Atake K, Nakamura T, Ueda N, Hori H, Katsuki A, Yoshimura R.

Front Psychiatry. 2018 May 29;9:232. doi: 10.3389/fpsyt.2018.00232. eCollection 2018.

9.

Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.

Rizos EN, Michalopoulou PG, Siafakas N, Stefanis N, Douzenis A, Rontos I, Laskos E, Kastania A, Zoumpourlis V, Lykouras L.

Neuropsychobiology. 2010;62(2):87-90. doi: 10.1159/000315438. Epub 2010 Jun 3.

PMID:
20523079
10.

Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics.

Fitzgerald D, Lucas S, Redoblado MA, Winter V, Brennan J, Anderson J, Harris A.

Aust N Z J Psychiatry. 2004 Jul;38(7):501-10.

PMID:
15255822
11.

Can cognitive deficits facilitate differential diagnosis between at-risk mental state for psychosis and depressive disorders?

Schulze C, Zimmermann R, Gschwandtner U, Pflueger MO, Rapp C, Studerus E, Riecher-Rössler A.

Early Interv Psychiatry. 2013 Nov;7(4):381-90. doi: 10.1111/eip.12004. Epub 2012 Nov 19.

PMID:
23164358
12.

Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study.

Sanada K, de Azúa SR, Nakajima S, Alberich S, Ugarte A, Zugasti J, Vega P, Martínez-Cengotitabengoa M, González-Pinto A.

Psychiatry Res. 2018 Oct;268:1-7. doi: 10.1016/j.psychres.2018.06.053. Epub 2018 Jun 28.

PMID:
29986171
13.

Association of serum BDNF and val66met polymorphism of the brain-derived neurotrophic factor in a sample of first psychotic episode patients.

Rizos EN, Siafakas N, Stefanis N, Douzenis A, Kontaxakis V, Laskos E, Kastania A, Zoumbourlis V, Lykouras L.

Psychiatriki. 2009 Oct;20(4):297-304.

PMID:
22218230
14.

The association between cognitive deficits and depressive symptoms in at-risk mental state: a comparison with first-episode psychosis.

Ohmuro N, Matsumoto K, Katsura M, Obara C, Kikuchi T, Hamaie Y, Sakuma A, Iizuka K, Ito F, Matsuoka H.

Schizophr Res. 2015 Mar;162(1-3):67-73. doi: 10.1016/j.schres.2015.01.008. Epub 2015 Jan 22.

PMID:
25618299
15.

BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism.

Sotiropoulou M, Mantas C, Bozidis P, Marselos M, Mavreas V, Hyphantis T, Antoniou K.

Life Sci. 2013 Mar 12;92(4-5):305-10. doi: 10.1016/j.lfs.2013.01.008. Epub 2013 Jan 15.

PMID:
23333821
16.

Neuropsychological deficits in individuals with an at risk mental state for psychosis - working memory as a potential trait marker.

Pflueger MO, Gschwandtner U, Stieglitz RD, Riecher-Rössler A.

Schizophr Res. 2007 Dec;97(1-3):14-24. Epub 2007 Oct 23.

PMID:
17936587
17.

Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.

Hori H, Yoshimura R, Katsuki A, Atake K, Igata R, Konishi Y, Nakamura J.

World J Biol Psychiatry. 2017 Aug;18(5):401-408. doi: 10.1080/15622975.2016.1212172. Epub 2016 Aug 15.

PMID:
27409727
18.

Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?

Bang M, Kim KR, Song YY, Baek S, Lee E, An SK.

Aust N Z J Psychiatry. 2015 May;49(5):462-70. doi: 10.1177/0004867414561527. Epub 2014 Nov 25.

PMID:
25425742
19.

Cognition and psychopathology in first-episode psychosis: are they related to inflammation?

Cabrera B, Bioque M, Penadés R, González-Pinto A, Parellada M, Bobes J, Lobo A, García-Bueno B, Leza JC, Bernardo M.

Psychol Med. 2016 Jul;46(10):2133-44. doi: 10.1017/S0033291716000659. Epub 2016 Apr 8.

PMID:
27055381
20.

Salivary cortisol in early psychosis: New findings and meta-analysis.

Chaumette B, Kebir O, Mam-Lam-Fook C, Morvan Y, Bourgin J, Godsil BP, Plaze M, Gaillard R, Jay TM, Krebs MO.

Psychoneuroendocrinology. 2016 Jan;63:262-70. doi: 10.1016/j.psyneuen.2015.10.007. Epub 2015 Oct 16.

PMID:
26520686

Supplemental Content

Support Center